FI101598B1 - Menetelmä pantopratsolia sisältävien oraalisten lääkevalmisteiden valmistamiseksi - Google Patents
Menetelmä pantopratsolia sisältävien oraalisten lääkevalmisteiden valmistamiseksiInfo
- Publication number
- FI101598B1 FI101598B1 FI935677A FI935677A FI101598B1 FI 101598 B1 FI101598 B1 FI 101598B1 FI 935677 A FI935677 A FI 935677A FI 935677 A FI935677 A FI 935677A FI 101598 B1 FI101598 B1 FI 101598B1
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- orally administered
- administered drug
- containing pantoprazole
- preparation containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH178891 | 1991-06-17 | ||
CH178891 | 1991-06-17 | ||
EP9201341 | 1992-06-13 | ||
PCT/EP1992/001341 WO1992022284A1 (fr) | 1991-06-17 | 1992-06-13 | Formes de presentation d'un medicament contenant du pantoprazol et administre par voie orale |
Publications (4)
Publication Number | Publication Date |
---|---|
FI935677A0 FI935677A0 (fi) | 1993-12-16 |
FI935677A FI935677A (fi) | 1993-12-16 |
FI101598B1 true FI101598B1 (fi) | 1998-07-31 |
FI101598B FI101598B (fi) | 1998-07-31 |
Family
ID=4218617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI935677A FI101598B (fi) | 1991-06-17 | 1993-12-16 | Menetelmä pantopratsolia sisältävien oraalisten lääkevalmisteiden valm istamiseksi |
Country Status (34)
Country | Link |
---|---|
US (1) | US5997903A (fr) |
EP (2) | EP0589981B1 (fr) |
JP (1) | JP3338052B2 (fr) |
KR (1) | KR100254021B1 (fr) |
CN (1) | CN1037932C (fr) |
AT (1) | ATE144416T1 (fr) |
AU (1) | AU683411B2 (fr) |
BG (1) | BG61796B1 (fr) |
CA (2) | CA2524168A1 (fr) |
CZ (1) | CZ281697B6 (fr) |
DE (2) | DE4219390A1 (fr) |
DK (1) | DK0589981T3 (fr) |
ES (1) | ES2096080T3 (fr) |
FI (1) | FI101598B (fr) |
GR (1) | GR3022154T3 (fr) |
HK (1) | HK1005851A1 (fr) |
HR (1) | HRP920162B1 (fr) |
IE (1) | IE77640B1 (fr) |
IL (1) | IL102096A (fr) |
LV (1) | LV11982B (fr) |
MX (1) | MX9202961A (fr) |
NO (1) | NO303714B1 (fr) |
NZ (1) | NZ243147A (fr) |
PL (1) | PL169951B1 (fr) |
RO (1) | RO117502B1 (fr) |
RU (1) | RU2089180C1 (fr) |
SI (1) | SI9200111A (fr) |
SK (1) | SK278566B6 (fr) |
TW (1) | TW224429B (fr) |
UA (1) | UA32525C2 (fr) |
WO (1) | WO1992022284A1 (fr) |
YU (1) | YU48263B (fr) |
ZA (1) | ZA924386B (fr) |
ZW (1) | ZW9392A1 (fr) |
Families Citing this family (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4504000A (en) * | 1993-04-27 | 2000-09-07 | Sepracor, Inc. | Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole |
SE9301489D0 (sv) | 1993-04-30 | 1993-04-30 | Ab Astra | Veterinary composition |
US6875872B1 (en) | 1993-05-28 | 2005-04-05 | Astrazeneca | Compounds |
DE4324014C2 (de) * | 1993-07-17 | 1995-06-08 | Byk Gulden Lomberg Chem Fab | Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung |
TW280770B (fr) | 1993-10-15 | 1996-07-11 | Takeda Pharm Industry Co Ltd | |
UA41946C2 (uk) * | 1994-07-08 | 2001-10-15 | Астра Актієболаг | Оральна фармацевтична складова одинична дозована форма у вигляді таблетки, спосіб її одержання, упаковка у вигляді блістера та спосіб інгібування секреції шлункової кислоти і/або лікування шлунково-кишкових запальних захворювань |
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
ES2094694B1 (es) * | 1995-02-01 | 1997-12-16 | Esteve Quimica Sa | Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion. |
SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
US5945124A (en) * | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
PL186605B1 (pl) * | 1995-09-21 | 2004-01-30 | Pharma Pass Llc | Tabletka lub mikrotabletka zawierająca rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol oraz sposób wytwarzania tabletek lub mikrotabletek zawierających rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol |
SI9700186B (sl) | 1997-07-14 | 2006-10-31 | Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. | Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin |
ES2137862B1 (es) * | 1997-07-31 | 2000-09-16 | Intexim S A | Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion. |
ATE500815T1 (de) * | 1997-12-08 | 2011-03-15 | Dietrich Rango | Neue suppositoriumsform mit säureempfindlichem wirkstoff |
DK173431B1 (da) | 1998-03-20 | 2000-10-23 | Gea Farmaceutisk Fabrik As | Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs |
JP4127740B2 (ja) * | 1998-04-20 | 2008-07-30 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 安定化したベンズイミダゾール系化合物含有組成物 |
US20020039597A1 (en) * | 1998-04-20 | 2002-04-04 | Koji Ukai | Stabilized compositions containing benzimidazole-type compounds |
ES2559766T3 (es) | 1998-05-18 | 2016-02-15 | Takeda Pharmaceutical Company Limited | Comprimidos disgregables en la boca |
ZA9810765B (en) * | 1998-05-28 | 1999-08-06 | Ranbaxy Lab Ltd | Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole. |
SI1105105T1 (sl) | 1998-08-12 | 2006-08-31 | Altana Pharma Ag | Oralna dajalna oblika za piridin-2-ilmetilsulfinil-1J-benzimidazole |
DE19843413C1 (de) | 1998-08-18 | 2000-03-30 | Byk Gulden Lomberg Chem Fab | Neue Salzform von Pantoprazol |
ATE300285T1 (de) | 1999-06-07 | 2005-08-15 | Altana Pharma Ag | Neue zubereitung und darreichungsform enthaltend einen säurelabilen protonenpumpeninhibitor |
ES2168043B1 (es) | 1999-09-13 | 2003-04-01 | Esteve Labor Dr | Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido. |
KR20020038759A (ko) | 1999-10-20 | 2002-05-23 | 다니구치 미즈오 | 벤즈이미다졸계 화합물 안정화 방법 |
DE19959419A1 (de) | 1999-12-09 | 2001-06-21 | Ratiopharm Gmbh | Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung |
DK1108425T3 (da) * | 1999-12-16 | 2005-09-26 | Medinfar Produtos Farmaceutico | Nye, stabile flerenhedspræparater, der indeholder substituerede benzimidazoler |
SK287105B6 (sk) * | 1999-12-20 | 2009-12-07 | Schering Corporation | Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním |
AU2277101A (en) * | 1999-12-20 | 2001-07-03 | Schering Corporation | Stable extended release oral dosage composition |
US6544556B1 (en) | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
WO2002045692A1 (fr) * | 2000-12-07 | 2002-06-13 | Altana Pharma Ag | Preparation pharmaceutique sous forme de suspension contenant un ingredient actif labile en milieu acide |
BR0212950A (pt) | 2001-09-28 | 2004-10-26 | Mcneil Ppc Inc | Formas de dosagens compósitas tendo uma porção inserida |
US20050163846A1 (en) * | 2001-11-21 | 2005-07-28 | Eisai Co., Ltd. | Preparation composition containing acid-unstable physiologically active compound, and process for producing same |
US20050220870A1 (en) * | 2003-02-20 | 2005-10-06 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
US8449911B2 (en) * | 2003-03-12 | 2013-05-28 | Takeda Pharmaceutical Company Limited | Drug composition having active ingredient adhered at high concentration to spherical core |
WO2004098573A1 (fr) * | 2003-05-08 | 2004-11-18 | Natco Pharma Limited | Composition pharmaceutique amelioree et stable contenant des benzimidazoles substitues et son procede de preparation |
PE20050150A1 (es) * | 2003-05-08 | 2005-03-22 | Altana Pharma Ag | Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo |
CL2004000983A1 (es) * | 2003-05-08 | 2005-03-04 | Altana Pharma Ag | Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y |
US20050147663A1 (en) * | 2003-07-17 | 2005-07-07 | Mohan Mailatur S. | Method of treatment for improved bioavailability |
RU2375048C2 (ru) * | 2003-07-17 | 2009-12-10 | Д-Р Редди'С Лабораторис Инк. | Фармацевтическая композиция с набухающим покрытием |
KR20060065632A (ko) * | 2003-07-17 | 2006-06-14 | 닥터 레디스 래보러토리즈, 인코포레이티드 | 팽창성 코팅을 갖는 약제학적 조성물 |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
EP1670469A1 (fr) * | 2003-09-18 | 2006-06-21 | ALTANA Pharma AG | Utilisation de pantoprazole comme capteur de radicaux |
TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
WO2005034924A1 (fr) * | 2003-10-14 | 2005-04-21 | Natco Pharma Limited | Pastilles a enrobage enterique comprenant de l'esomeprazole, capsule de gelatine dure renfermant celles-ci et procede de preparation associe |
US20050175689A1 (en) * | 2003-10-27 | 2005-08-11 | Yamanouchi Pharmaceutical Co., Ltd. | Coated fine particles containing drug for intrabuccally fast disintegrating tablet |
CA2543172A1 (fr) * | 2003-10-31 | 2005-05-19 | Dexcel Ltd. | Formulation stable contenant du lansoprazole |
WO2005046634A2 (fr) * | 2003-11-14 | 2005-05-26 | Siegfried Generics International Ag | Forme galenique resistant au suc gastrique |
HU227317B1 (en) * | 2003-11-25 | 2011-03-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Enteric coated tablet containing pantoprazole |
EP1694300A4 (fr) * | 2003-12-09 | 2009-04-29 | Pharmasset Inc | Procedes de dosage destines a une therapie antivirale a base de beta-d-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine |
CA2554271A1 (fr) * | 2004-02-10 | 2005-08-25 | Santarus, Inc. | Combinaison d'un inhibiteur de la pompe a protons, d'un tampon et d'un medicament anti-inflammatoire non steroidien |
KR20070010132A (ko) * | 2004-03-25 | 2007-01-22 | 아스텔라스세이야쿠 가부시키가이샤 | 솔리페나신 또는 그의 염의 고형 제제용 조성물 |
EP1728512A1 (fr) * | 2004-03-26 | 2006-12-06 | Eisai R&D Management Co., Ltd. | Preparation de lessivage maitrise et procede de fabrication de ladite preparation |
CA2565083C (fr) | 2004-05-07 | 2014-07-08 | Altana Pharma Ag | Nouvelle forme posologique pharmaceutique et procede de fabrication |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20050281876A1 (en) * | 2004-06-18 | 2005-12-22 | Shun-Por Li | Solid dosage form for acid-labile active ingredient |
US20060024362A1 (en) | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
DE102004042139B4 (de) * | 2004-08-31 | 2009-06-10 | Aristocon Verwaltungs- Gmbh | Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit |
EP1830822A1 (fr) * | 2004-12-24 | 2007-09-12 | LEK Pharmaceuticals D.D. | Composition pharmaceutique stable comprenant un substance active sous la forme d'une solution solide |
CA2591761A1 (fr) * | 2004-12-27 | 2006-07-06 | Astellas Pharma Inc. | Preparation pharmaceutique granulaire stable de solifenacineou de son sel |
WO2006085335A2 (fr) * | 2005-01-03 | 2006-08-17 | Lupin Limited | Composition pharmaceutique de substances labiles acides |
US8673352B2 (en) | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
EP1895990A2 (fr) * | 2005-05-13 | 2008-03-12 | Combino Pharm, S.L. | Formulations contenant de l acide libre de pantoprazole et les sels de ce dernier |
US7815939B2 (en) * | 2005-07-20 | 2010-10-19 | Astellas Pharma Inc. | Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms |
EP1747776A1 (fr) * | 2005-07-29 | 2007-01-31 | KRKA, tovarna zdravil, d.d., Novo mesto | Composition pharmaceutique comprenant du pantoprazole granulaire |
US20090148519A1 (en) * | 2005-09-29 | 2009-06-11 | Yasuhiro Zaima | Pulsed-release preparation having improved disintegration properties in vivo |
AU2006299424A1 (en) * | 2005-10-06 | 2007-04-12 | Auspex Pharmaceuticals, Inc. | Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties |
CA2634232C (fr) | 2005-12-28 | 2013-08-20 | Takeda Pharmaceutical Company Limited | Procede de production de preparation solide se desintegrant dans la cavite orale |
US8865212B2 (en) | 2006-01-16 | 2014-10-21 | Jubilant Generics Limited | Stable pharmaceutical formulation of an acid labile compound and process for preparing the same |
EP2026768B1 (fr) * | 2006-06-01 | 2018-02-28 | Dexcel Pharma Technologies Ltd. | Formulation pharmaceutique comprenant des unités multiples |
GB2444593B (en) | 2006-10-05 | 2010-06-09 | Santarus Inc | Novel formulations for immediate release of proton pump inhibitors and methods of using these formulations |
US20100105738A1 (en) * | 2006-10-06 | 2010-04-29 | Mitsuru Mizuno | Extended release formulations of a proton pump inhibitor |
US20080103169A1 (en) | 2006-10-27 | 2008-05-01 | The Curators Of The University Of Missouri | Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same |
SI2124884T1 (sl) | 2006-12-22 | 2019-09-30 | Ironwood Pharmaceuticals, Inc. | Pripravki, ki obsegajo sekvestrante žolčnih kislin, za zdravljenje motenj požiralnika |
WO2009034558A2 (fr) | 2007-09-14 | 2009-03-19 | Wockhardt Research Centre | Compositions de rheine ou de diacereine |
US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
DE102010052847A1 (de) * | 2010-11-29 | 2012-05-31 | Temmler Werke Gmbh | Verfahren zur Herstellung einer PPI-haltigen pharmazeutischen Zubereitung |
WO2014113377A1 (fr) | 2013-01-15 | 2014-07-24 | Ironwood Pharmaceuticals, Inc. | Forme posologique orale à libération prolongée à rétention gastrique d'un agent séquestrant d'acide biliaire |
WO2016126625A1 (fr) | 2015-02-03 | 2016-08-11 | Ironwood Pharmaceuticals, Inc. | Méthodes de traitement de troubles gastro-intestinaux supérieurs de gerd réfractaire à ppi |
EP3288556A4 (fr) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Compositions à désintégration par voie orale |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
CN108065443B (zh) * | 2017-12-30 | 2020-02-28 | 厦门金达威维生素有限公司 | 斥水型双包被微胶囊及其制备方法 |
CN114569579B (zh) | 2020-12-02 | 2023-10-31 | 丽珠医药集团股份有限公司 | 肠溶微丸、其制备方法和包含它的制剂 |
WO2024075017A1 (fr) | 2022-10-04 | 2024-04-11 | Zabirnyk Arsenii | Inhibition de calcification de valve aortique |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2189699A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
JPH0768125B2 (ja) * | 1988-05-18 | 1995-07-26 | エーザイ株式会社 | 酸不安定化合物の内服用製剤 |
-
1992
- 1992-06-02 YU YU57692A patent/YU48263B/sh unknown
- 1992-06-03 IL IL10209692A patent/IL102096A/en not_active IP Right Cessation
- 1992-06-12 HR HR01788/91-0A patent/HRP920162B1/xx not_active IP Right Cessation
- 1992-06-13 RO RO93-01691A patent/RO117502B1/ro unknown
- 1992-06-13 CZ CS932764A patent/CZ281697B6/cs not_active IP Right Cessation
- 1992-06-13 AU AU19746/92A patent/AU683411B2/en not_active Expired
- 1992-06-13 ES ES92912364T patent/ES2096080T3/es not_active Expired - Lifetime
- 1992-06-13 EP EP92912364A patent/EP0589981B1/fr not_active Expired - Lifetime
- 1992-06-13 AT AT92912364T patent/ATE144416T1/de active
- 1992-06-13 DK DK92912364.4T patent/DK0589981T3/da active
- 1992-06-13 CA CA002524168A patent/CA2524168A1/fr not_active Expired - Lifetime
- 1992-06-13 RU RU9293058536A patent/RU2089180C1/ru active
- 1992-06-13 US US08/167,961 patent/US5997903A/en not_active Expired - Lifetime
- 1992-06-13 WO PCT/EP1992/001341 patent/WO1992022284A1/fr active IP Right Grant
- 1992-06-13 DE DE4219390A patent/DE4219390A1/de not_active Ceased
- 1992-06-13 KR KR1019930703898A patent/KR100254021B1/ko not_active IP Right Cessation
- 1992-06-13 EP EP92110021A patent/EP0519365A1/fr active Pending
- 1992-06-13 DE DE59207438T patent/DE59207438D1/de not_active Expired - Lifetime
- 1992-06-13 SK SK1287-93A patent/SK278566B6/sk not_active IP Right Cessation
- 1992-06-13 CA CA002109697A patent/CA2109697C/fr not_active Expired - Lifetime
- 1992-06-13 PL PL92301957A patent/PL169951B1/pl unknown
- 1992-06-13 JP JP51105392A patent/JP3338052B2/ja not_active Expired - Lifetime
- 1992-06-13 UA UA93004305A patent/UA32525C2/uk unknown
- 1992-06-15 NZ NZ243147A patent/NZ243147A/en not_active IP Right Cessation
- 1992-06-15 ZW ZW93/92A patent/ZW9392A1/xx unknown
- 1992-06-16 ZA ZA924386A patent/ZA924386B/xx unknown
- 1992-06-17 CN CN92104690A patent/CN1037932C/zh not_active Expired - Lifetime
- 1992-06-17 SI SI19929200111A patent/SI9200111A/sl unknown
- 1992-06-17 MX MX9202961A patent/MX9202961A/es unknown
- 1992-07-01 IE IE921733A patent/IE77640B1/en not_active IP Right Cessation
- 1992-07-07 TW TW081105370A patent/TW224429B/zh not_active IP Right Cessation
-
1993
- 1993-12-10 BG BG98286A patent/BG61796B1/bg unknown
- 1993-12-16 FI FI935677A patent/FI101598B/fi not_active IP Right Cessation
- 1993-12-16 NO NO934648A patent/NO303714B1/no not_active IP Right Cessation
-
1996
- 1996-12-24 GR GR960403621T patent/GR3022154T3/el unknown
-
1997
- 1997-10-23 LV LVP-97-207A patent/LV11982B/lv unknown
-
1998
- 1998-06-08 HK HK98105037A patent/HK1005851A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI101598B1 (fi) | Menetelmä pantopratsolia sisältävien oraalisten lääkevalmisteiden valmistamiseksi | |
EE04800B1 (et) | Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks | |
IS1709B (is) | Aðferð til framleiðslu á þrýstingsúðasamsetningumtil inntöku lyfja með innöndun | |
NO871790D0 (no) | Fremgangsmaate for fremstilling av et oralt farmasoeytisk preparat. | |
RU93058536A (ru) | Орально вводимая форма лекарственного средства на основе пантопразола | |
IT8619675A0 (it) | Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale. | |
GEP20033014B (en) | Enteric Coated Pharmaceutical Composition and Method of Manufacturing | |
MX9207676A (es) | Metodo para preparar medicamentos de administracion oral, con recubrimiento enterico y que contienen compuestos inestables a los acidos. | |
FI881978A0 (fi) | Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi | |
ITMI912212A0 (it) | Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica | |
AU2293892A (en) | Enzyme-sensitive enteric preparation for oral administration | |
EP0271151A3 (fr) | Formes de dosage de l'azumolène | |
NO910186L (no) | Fremgangsmaate for fremstilling av et oralt inhalerbart, farmasoeytisk atropin-salbutamol-aerosolpreparat. | |
GB9420748D0 (en) | 1,5 benzodiazepine derivatives | |
ES2118451T3 (es) | Preparado medicamentoso oral que contiene diclofenaco sodico y un acido organico. | |
NO924385D0 (no) | Preparat for oral langtidsbehandling av astma | |
IT9021021A0 (it) | Composizioni farmaceutiche per la somministrazione orale di irudina | |
PT97163A (pt) | Processo para a preparacao de uma composicao farmaceutica contendo n-fenil-n-metil-1,2-hidro-4-hidroxi-1-metil-2-oxo-quinolina-3-carboxamida | |
DK117291D0 (da) | Doseringsform til oral indgift af laegemiddelstoffer | |
DE3780893D1 (de) | Formulierung zur herstellung von arzneimitteln mit verzoegerter freisetzung zur oralen gabe. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer of assignment of patent |
Owner name: NYCOMED GMBH Free format text: NYCOMED GMBH |
|
MA | Patent expired |